Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Stable AnginaUnstable Angina
Interventions
DEVICE

Drug Coated Balloon

If post balloon angioplasty FFR is more than 0.80, either DCB treatment or BMS implantation will be carried out based on randomization of 1:1. DCB (SeQuent Please paclitaxel-coated balloon catheter, B. Braun, Melsungen, Germany) will be applied at the predilated lesions. PCB will be delivered rapidly and inflated for 60 seconds with nominal pressure.

DEVICE

Bare Metal Stent

BMS (Vision®) will be applied at the predilated lesions after angiographic confirmation of the target lesion.

Trial Locations (1)

682-714

Ulsan University Hospital, Ulsan

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

lead

Ulsan University Hospital

OTHER

NCT02456402 - Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions | Biotech Hunter | Biotech Hunter